Clinical Trials Browser

Phase 4 × INDUSTRY × Genitourinary × Clear all

Prostatic Neoplasms

Prostatic Neoplasms

Carcinoma, Transitional Cell

Breast Neoplasms, Carcinoma, Hepatocellular, Prostatic Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors

Metastatic Castration-resistant Prostate Cancer

Prostatic Neoplasms

Prostatic Neoplasms

Kidney Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Metastatic Castration Resistant Prostate Cancer

Prostatic Neoplasms

Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms

Urinary Bladder Neoplasms

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

Prostatic Neoplasms, Peripheral Nerve Injuries

Hyperparathyroidism, Hyperparathyroidism, Secondary, Neoplasm Metastasis, Chronic Kidney Disease-Mineral and Bone Disorder

Prostatic Neoplasms

Advanced Prostate Cancer

Carcinoma, Renal Cell

Carcinoma, Renal Cell

Prostate Cancer Metastatic

Prostatic Neoplasms

Prostatic Neoplasms

Carcinoma, Renal Cell, Melanoma

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms

Carcinoma, Renal Cell

Neoplasm Metastasis, Prostatic Neoplasms

Carcinoma, Renal Cell

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Carcinoma, Renal Cell, Kidney Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Pain, Prostatic Neoplasms

Breast Neoplasms, Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Hyperplasia, Prostatic Neoplasms

Carcinoma, Renal Cell, Neoplasm Metastasis

Prostatic Neoplasms

Prostatic Neoplasms

Prostate Cancer Metastatic

Kidney Failure, Chronic

Prostatic Neoplasms

Prostatic Neoplasms

Urinary Bladder Neoplasms

Clinical Trials

A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)

A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)

A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer

ODYSSEY

Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations

MIRROR

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

CheckMate 7C9

GREAT

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy

Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer

A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer

A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients

ABLE-42

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer

ACTIVE

PLATO

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.

CHECKMATE 920

CheckMate 374

CARD

PRIZE

A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

PRIORITI

Study of Nivolumab for Advanced Cancers in India

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.

A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment

MARC-2

FLIPPER

Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib

Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer

EFFECT

Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy

Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy

Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases

Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases

Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer

PEGAZUS

Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer

Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis

Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer

PROSPECTA

Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer

The Effect of Balance PD Solution on the Peritoneal Membrane in Patients on Automated Peritoneal Dialysis

Global Performance Evaluation of the AMS CONTINUUM™ Device

Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer

Recurrence of Bladder Cancer After Transurethral Resection With Hexvix